We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate
PL BioScience has raised $8.5M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
PL BioScience's investors include Avant Bio, TechVision Fund, Brightlands Venture Partners, better ventures, LePure Biotech.
PL BioScience is headquartered in Aachen, Germany.
We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate
PL BioScience is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PL BioScience — Funding & Investors." VCBacked, August 8, 2024, https://www.vcbacked.co/company/pl-bioscience. Accessed September 14, 2026.
VCBacked. (2024). PL BioScience — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/pl-bioscience
{{cite web |title=PL BioScience — Funding & Investors |url=https://www.vcbacked.co/company/pl-bioscience |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated